Meeting Banner
Abstract #2959

Metabolic Biomarkers of TERT expression in glioblastoma

Vinay Ayyappan1, Georgios Batsios2, Nick Stevers3, Abigail R Molloy2, Aliya A Lakhani2, Joseph F Costello3, Pavithra Viswanath2, and Sabrina M Ronen2
1John Hopkins University, Baltimore, MD, United States, 2Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, CA, United States, 3Neurological Surgery, University of California San Francisco, San Francisco, CA, United States

Expression of telomerase reverse transcriptase (TERT) is essential for tumor proliferation, including in primary glioblastomas. Inhibiting TERT expression is also a therapeutic strategy for glioblastomas. The goal of this study was to identify non-invasive magnetic resonance spectroscopy (MRS)-detectable metabolic biomarkers of TERT expression in glioblastoma cells. Our studies indicate that TERT expression is linked to redox, as indicated by higher 1H MRS-detectable reduced glutathione, and higher 13C MRS-detectable flux of glucose via the pentose phosphate pathway in TERT-expressing GBM cells. Hyperpolarized [U-13C, U-2H]glucose can monitor TERT expression in GBM cells, and may serve to noninvasively probe TERT expression in glioblastomas.

This abstract and the presentation materials are available to 2020 meeting attendees and eLibrary customers only; a login is required.

Join Here